The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Why is Saudi Arabia spending a king’s ransom on sports? The Middle East powerhouse doesn’t care if you call it sportswashing.
The energy titan has extended the timeline for its plan to reduce its “carbon intensity.”
Despite tariffs, the US imported a record number of panels through November of last year.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Southwest and Alaska said that the manufacturer’s uncertain status makes it hard to forecast the year ahead.
The vacation rental company is ramping up privacy as it continues to battle customer satisfaction issues.
Bioprospecting for genes of new species in the world’s oceans has become complex and extremely lucrative.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.
The future of the connected car may come with a lot of driver data collection for the sake of personalization.
The retailer is looking to spark its turnaround with its own version of an e-commerce membership.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.